A phase I Study of ecteinascidin 743(E) and capecitabine (C) in patients (pts) with advanced solid malignancies.

被引：0
|
作者：
Holden, SN
Rivera, E
Basche, M
Gore, L
Raj, SKS
O'Bryant, CL
Grolnic, S
Hunt, J
Brillhart, B
Van de Velde, H
Roberts, D
Rodgers, J
Eckhardt, SG
机构：
[1] Univ Colorado, Ctr Canc, Denver, CO 80202 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Johnson & Johnson Pharmaceut R&D, Beerse, Belgium
[4] Johnson & Johnson Pharmaceut R&D, Titusville, NJ USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6080S / 6080S
页数：1
相关论文
共 50 条
  • [21] Phase I dose escalation, pharmacokinetic, and biomarker study of imatinib mesylate plus capecitabine in advanced solid tumor malignancies.
    Favaro, J. P.
    Petros, W.
    Hong, T.
    Fernando, N.
    Bendell, J. C.
    Gockerman, J. P.
    George, D. J.
    Williams-Truax, R.
    Nixon, A.
    Yu, D.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 144S - 144S
  • [22] Phase I and pharmacokinetic (PK) study of dasatinib (D) and cetuximab (C) in patients (pts) with advanced solid malignancies
    Feinstein, T. M.
    Agrawal, S.
    Stoller, R. G.
    Egorin, M. J.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Phase I trial of cetuximab (C) and dasatinib (D) in patients (pts) with advanced solid malignancies
    Esteve, F. R.
    Stoller, R. G.
    Josephson, A.
    Grandis, J. R.
    Egorin, M. J.
    Argiris, A. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Phase I study of elisidepsin (E) in combination with carboplatin (C) in patients (pts) with advanced solid tumors
    Faivre, S. J.
    Ropert, S.
    Coronado, C.
    Alcantara, J.
    De Miguel, B.
    Soto, A.
    Szyldergemajn, S. A.
    Loussilaho, G.
    Mir, O.
    Goldwasser, F.
    Raymond, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] A phase I study of sirolimus (rapamycin) and bevacizumab in patients with advanced malignancies.
    Cohen, E. E.
    Sharma, M.
    Janisch, L. A.
    Stadler, W. M.
    Kang, S. P.
    Fleming, G. F.
    Ratain, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Gore, Lia
    Rivera, E.
    Basche, M.
    Moulder-Thompson, S. L.
    Li, J.
    Eppers, S.
    Grolnic, S.
    O'Bryant, C.
    Cleere, D.
    Elsayed, Y. A.
    Eckhardt, S. G.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1942 - 1949
  • [27] A phase I study of reolysin given intravenously to patients with advanced malignancies.
    Vidal, L.
    Pandha, H.
    Spicer, J.
    Harrington, K. J.
    Allen, S.
    Leader, D.
    Coffey, M.
    Thompson, B.
    Kaye, S.
    De-Bono, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 136S - 136S
  • [28] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Lia Gore
    E. Rivera
    M. Basche
    S. L. Moulder-Thompson
    J. Li
    S. Eppers
    S. Grolnic
    C. O’Bryant
    D. Cleere
    Y. A. Elsayed
    S. G. Eckhardt
    Investigational New Drugs, 2012, 30 : 1942 - 1949
  • [29] A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Tang, P.
    Oza, A.
    Townsley, C.
    Siu, L.
    Pond, G.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J.
    Chen, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A phase I dose finding study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D.
    Evans, T. R.
    Roelvink, M.
    Saro, J. M.
    Bezodis, P.
    Copalu, W.
    Das, A.
    Crosswell, G.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345